Alzheimer5 s disease assessment scale-cognitive相关文献:
Precuneus magnetic stimulation for Alzheimer's disease: a randomized, sham-controlled trial.
Koch G, Casula EP, Bonnì S, Borghi I, Assogna M, Minei M, Pellicciari MC, Motta C, D'Acunto A, Porrazzini F, Maiella M, Ferrari C, Caltagirone C, Santarnecchi E, Bozzali M, Martorana A.
Brain. 2022 Nov 21;145(11):3776-3786. doi: 10.1093/brain/awac285.
PMID:36281767
The Integrated Alzheimer's Disease Rating Scale (iADRS) Findings from the EXPEDITION3 Trial.
Galantamine for dementia due to Alzheimer's disease and mild cognitive impairment.
Lim AWY, Schneider L, Loy C.
Cochrane Database Syst Rev. 2024 Nov 5;11(11):CD001747. doi: 10.1002/14651858.CD001747.pub4.
PMID:39498781
Donepezil for dementia due to Alzheimer's disease.
Birks JS, Harvey RJ.
Cochrane Database Syst Rev. 2018 Jun 18;6(6):CD001190. doi: 10.1002/14651858.CD001190.pub3.
PMID:29923184
The Alzheimer's Disease Assessment Scale-Cognitive Subscale (ADAS-Cog): Modifications and Responsiveness in Pre-Dementia Populations. A Narrative Review.
Alzheimer's Disease Assessment Scale - Cognitive Subscale (ADAS-Cog): Normative Data for the Portuguese Population.
Nogueira J, Freitas S, Duro D, Tábuas-Pereira M, Guerreiro M, Almeida J, Santana I.
Acta Med Port. 2018 Feb 28;31(2):94-100. doi: 10.20344/amp.8859. Epub 2018 Feb 28.
PMID:29596768
Is the Alzheimer's Disease Assessment Scale-Cognitive Subscale Useful in Screening for Mild Cognitive Impairment and Alzheimer's Disease? A Systematic Review.
Alzheimer's Disease Assessment Scale--cognitive in clinical practice.
Peña-Casanova J.
Int Psychogeriatr. 1997;9 Suppl 1:105-14.
PMID:9447433
State, trait, and accumulated features of the Alzheimer's Disease Assessment Scale Cognitive Subscale (ADAS-Cog) in mild Alzheimer's disease.
Cogo-Moreira H, Krance SH, Wu CY, Lanctôt KL, Herrmann N, Black SE, MacIntosh BJ, Rabin JS, Eid M, Swardfager W; Alzheimer's Disease Neuroimaging Initiative.